V. Deshmukh

1.6k total citations · 1 hit paper
28 papers, 1.0k citations indexed

About

V. Deshmukh is a scholar working on Surgery, Rheumatology and Pharmacology. According to data from OpenAlex, V. Deshmukh has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Rheumatology and 5 papers in Pharmacology. Recurrent topics in V. Deshmukh's work include Osteoarthritis Treatment and Mechanisms (7 papers), Knee injuries and reconstruction techniques (4 papers) and Immune Cell Function and Interaction (4 papers). V. Deshmukh is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (7 papers), Knee injuries and reconstruction techniques (4 papers) and Immune Cell Function and Interaction (4 papers). V. Deshmukh collaborates with scholars based in United States, India and Japan. V. Deshmukh's co-authors include Peter G. Schultz, Brian R. Lawson, Virginie Tardif, Jonathan G. Swoboda, Bilal E. Kerman, Argyrios N. Theofilopoulos, Costas A. Lyssiotis, Insha Ahmad, Hyung Joon Kim and Luke L. Lairson and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

V. Deshmukh

25 papers receiving 979 citations

Hit Papers

A regenerative approach to the treatment of multiple scle... 2013 2026 2017 2021 2013 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Deshmukh United States 10 424 242 192 153 143 28 1.0k
Violaine Harris United States 20 953 2.2× 238 1.0× 189 1.0× 80 0.5× 70 0.5× 31 1.5k
Michael R. Douglas United Kingdom 18 590 1.4× 98 0.4× 105 0.5× 40 0.3× 45 0.3× 25 1.3k
Marta Segarra Germany 19 495 1.2× 88 0.4× 134 0.7× 40 0.3× 178 1.2× 24 1.1k
Craig A. Krekoski Canada 15 606 1.4× 181 0.7× 210 1.1× 41 0.3× 239 1.7× 18 1.8k
Cristina Fernández‐Valle United States 23 603 1.4× 244 1.0× 165 0.9× 66 0.4× 68 0.5× 55 1.8k
Robert G. Farrer United States 13 386 0.9× 130 0.5× 39 0.2× 74 0.5× 117 0.8× 26 947
Yifeng Lin China 19 726 1.7× 151 0.6× 184 1.0× 17 0.1× 102 0.7× 42 1.4k
Thomas Zeis Switzerland 18 290 0.7× 183 0.8× 76 0.4× 49 0.3× 334 2.3× 21 813
Alwin Kamermans Netherlands 19 881 2.1× 69 0.3× 132 0.7× 37 0.2× 420 2.9× 27 1.6k
Chung Heon Ryu South Korea 19 553 1.3× 144 0.6× 226 1.2× 19 0.1× 85 0.6× 25 1.2k

Countries citing papers authored by V. Deshmukh

Since Specialization
Citations

This map shows the geographic impact of V. Deshmukh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Deshmukh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Deshmukh more than expected).

Fields of papers citing papers by V. Deshmukh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Deshmukh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Deshmukh. The network helps show where V. Deshmukh may publish in the future.

Co-authorship network of co-authors of V. Deshmukh

This figure shows the co-authorship network connecting the top 25 collaborators of V. Deshmukh. A scholar is included among the top collaborators of V. Deshmukh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Deshmukh. V. Deshmukh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Deshmukh, V., Maureen Ibanez, Ying Wei, et al.. (2020). A small-molecule inhibitor of the Wnt pathway, lorecivivint (SM04690), as a potential disease-modifying agent for the treatment of degenerative disc disease. The Spine Journal. 20(9). 1492–1502. 8 indexed citations
5.
Deshmukh, V., et al.. (2018). Experimental tendinopathy treatment with SM04755, a topical small molecule inhibitor of the WNT pathway. Osteoarthritis and Cartilage. 26. S24–S24. 1 indexed citations
6.
Deshmukh, V., T. Seo, Christopher J. Swearingen, & Yusuf Yazıcı. (2018). SM04690, a WNT pathway inhibitor: anti-inflammatory and cartilage protective effects in preclinical osteoarthritis models. Osteoarthritis and Cartilage. 26. S64–S64. 1 indexed citations
7.
Deshmukh, V., et al.. (2018). THU0046 Small molecule inhibitor of the wnt pathway (SM04755) as a potential topical treatment for psoriasis. Annals of the Rheumatic Diseases. 77. 249–249. 3 indexed citations
8.
Deshmukh, V., M. Pedraza, Charlene F. Barroga, John T. Seykora, & Yusuf Yazıcı. (2017). 712 A small molecule modulator of the wnt pathway (SM04554) as a potential topical treatment for androgenetic alopecia (AGA). Journal of Investigative Dermatology. 137(5). S122–S122. 2 indexed citations
9.
Deshmukh, V., Charlene F. Barroga, Carine Bossard, et al.. (2017). A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee. Osteoarthritis and Cartilage. 26(1). 18–27. 176 indexed citations
10.
Deshmukh, V., Charlene F. Barroga, Maureen Ibanez, et al.. (2017). Anti-inflammatory Properties of SM04690, a Small Molecule Inhibitor of the Wnt Pathway as a Potential Treatment for Knee Osteoarthritis. Osteoarthritis and Cartilage. 25. S310–S311. 2 indexed citations
11.
Barroga, Charlene F., V. Deshmukh, S. KC, et al.. (2017). Discovery of a small molecule inhibitor of the Wnt pathway (SM04690) as a potential treatment for degenerative disc disease. Osteoarthritis and Cartilage. 25. S400–S400. 5 indexed citations
12.
Deshmukh, V., Charlene F. Barroga, Maureen Ibanez, et al.. (2017). SAT0549 Anti-inflammatory properties of SM04690, a small molecule inhibitor of the wnt pathway as a potential treatment for knee osteoarthritis. Annals of the Rheumatic Diseases. 76. 984–984. 1 indexed citations
13.
Hood, John, et al.. (2016). Discovery of a small molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying treatment for knee osteoarthritis. Osteoarthritis and Cartilage. 24. S14–S15. 7 indexed citations
14.
Hood, John, et al.. (2016). OP0069 Discovery of A Small Molecule Inhibitor of The WNT Pathway (SM04690) as A Potential Disease Modifying Treatment for Knee Osteoarthritis. Annals of the Rheumatic Diseases. 75. 81–81. 1 indexed citations
15.
Wang, Rongsheng E., Tao Liu, Yu Cao, et al.. (2015). An Immunosuppressive Antibody–Drug Conjugate. Journal of the American Chemical Society. 137(9). 3229–3232. 84 indexed citations
16.
Lu, Hua, Quan Zhou, V. Deshmukh, et al.. (2014). Targeting Human C‐Type Lectin‐like Molecule‐1 (CLL1) with a Bispecific Antibody for Immunotherapy of Acute Myeloid Leukemia. Angewandte Chemie International Edition. 53(37). 9841–9845. 64 indexed citations
17.
Kularatne, Sumith A., V. Deshmukh, Jennifer Ma, et al.. (2014). A CXCR4‐Targeted Site‐Specific Antibody–Drug Conjugate. Angewandte Chemie International Edition. 53(44). 11863–11867. 57 indexed citations
18.
Sahu, Ram Kumar, et al.. (2013). In vitro techniques to assess the proficiency of skin care cosmetic formulations. Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review. 7(14). 97–97. 41 indexed citations
19.
Deshmukh, V., Virginie Tardif, Costas A. Lyssiotis, et al.. (2013). A regenerative approach to the treatment of multiple sclerosis. Nature. 502(7471). 327–332. 403 indexed citations breakdown →
20.
Kularatne, Sumith A., V. Deshmukh, Marco Gymnopoulos, et al.. (2013). Recruiting Cytotoxic T Cells to Folate‐Receptor‐Positive Cancer Cells. Angewandte Chemie International Edition. 52(46). 12101–12104. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026